Tuesday October 20th, 2015 at 9:30AM
BriaCell Therapeutics Corp (OTCQB: BCTXF) (TSX VENTURE: BCT) (“BriaCell”, the “Company”, or “BCT”) an immuno-oncology company focused on the development of novel cancer treatments, today announced that the Company will present at the 14th Annual BIO Investor Forum in San Francisco, California on Tuesday October 20th, 2015 at 9:30AM Pacific Time (12:30PM Eastern Time). Joseph Wagner, Ph.D., BriaCell’s President and Chief Executive Officer, will provide an update on the manufacturing and clinical development of BriaCell’s lead immuno-oncology product, BriaVax™.
After many months of operational developments, BriaCell;trade is scheduled to attend numerous meetings with large pharmaceutical companies, venture capital firms, and institutions.
Details of the BriaCell presentation are as follows:
Event: 2015 BIO Investor Forum
Date: Tuesday, October 20, 2015
Time: 9:30-9:55 AM Pacific Time (12:30-12:55 PM Eastern Time)
Location: The Parc 55 Hotel, 55 Cyril Magnin St, San Francisco, CA 94102
INDIVIDUALS MAY ACCESS A LIVE AUDIO WEBCAST OF BRIACELL’S PRESENTATION BY VISITING THE BRIACELL THERAPEUTICS CORP WEBCASTRead More